Company intelligence / Profile preview

TrainHealth

Palo Alto, California, United Statestrainfesadvanced.com ↗

Ownership: Private
Development stage: Other

Overview

TrainHealth’s "TrainFES Advanced" is an FDA-cleared neuromuscular electrical stimulator designed to improve outcomes in neurological rehabilitation. Clinical studies have shown significant improvements in gait and balance for stroke patients using the device at home over six weeks, with high adherence rates (~84%) and up to 40% improvement in motivation and usability metrics. The technology is being adopted by major clinics globally.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy (Functional Electrical Stimulation, FES)
Industry: Therapeutic Medical Devices

Partnerships

Collaborations with top-tier universities such as Stanford University (StartX)University of Illinois ChicagoUCSF Innovator’s programMassChallenge accelerator network

Beyond the preview

Go deeper on TrainHealth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TrainHealth.

Explore the full profile